It has been reported that AS-IV attenuates cognitive impairments partly through its anti-inflammatory activities via the suppression of inflammasome overactivation and the Toll-Like Receptor 4 (TLR4) signaling pathway [27]. This evidence concerns the gene TLR4 and Cognitive impairment.